ABSTRACT
INTRODUCTION
The luciferase reporter gene system is widely used for the delineation and functional analysis of basal promoter and enhancer elements of eukaryotic genes. Several different luciferase reporter gene vectors, including pGL2-Basic and pGL3-Basic (Promega, Madison, WI, USA), referred to hereafter as pGL2 and pGL3, respectively, are available from individual and commercial sources. One of the problems associated with the use of luciferase reporter vectors is the high background expression resulting from the interaction of general transcription factors with cryptic promoter elements in the vector sequences (4) . Furthermore, endogenous or exogenous (produced from transfected plasmids) transcription factors in the host cell could also interact with their cognate consensus DNA elements that may occur at random in the vector sequence, leading to spurious background luciferase expression (8, 19) . These effects are further complicated by the high sensitivity of detection achieved with the currently available luciferase reporter assay systems. Recent versions of the luciferase reporter vectors, such as pGL3, have been engineered with polyadenylation sites upstream and downstream of the luciferase coding region to minimize the effect of cryptic promoter and enhancer elements (4, 17, 19) . However, the success of these modifications in obviating the problem remains largely unclear.
Here, we demonstrate that cryptic enhancer elements in pGL3, a promoterless and enhancerless luciferase reporter vector, respond to the osteoblast-specific transcription factor Cbfa1. Expression of Cbfa1 in COS1 cells, and SaOS2 osteoblast-like osteosarcoma cells, resulted in a 3-6-fold increase in luciferase expression from pGL3. Similarly, the expression of the estrogen receptor (ER α ) also stimulated luciferase expression from pGL2 and pGL3. The data presented in this paper highlight the limitations of pGL2 and pGL3 reporter vectors while emphasizing the need to perform appropriate controls and exercise caution in interpreting the results in promoter transactivation and repression studies.
MATERIALS AND METHODS

Plasmids
The pGL2 and pGL3 plasmids were obtained from Promega, and the p β galBasic plasmid was obtained from Clontech Laboratories (Palo Alto, CA, USA). The pCMV5 control vector and pCMV5-Cbfa1, which contains the Cbfa1 coding sequence under the control of the CMV promoter (6), were obtained from Dr. Gerard Karsenty, Baylor College of Medicine (Houston, TX, USA). The ER αexpression plasmid contains the coding sequence of the receptor cloned in pCMV5, and the c-fos construct has the coding sequence of the c-fos protooncogene cloned in the vector Crtv-12.
Cell Culture and DNA Transfection
The monkey kidney cell line COS-1 was obtained from ATCC (Bethesda, MD, USA) and was grown in DMEM, supplemented with 10% fetal bovine serum and antibiotics (Life Technologies, Gaithersburg, MD, USA). The human osteosarcoma cell line SaOS2 was grown in DMEM/F-12 (3:1), supplemented with 10% FBS, 2 mM L-Glutamine and 20 mM HEPES (Life Technologies). Cells (1 ×10 5 ) were plated per well in six-well plates and incubated for 24 h at 37°C in the presence of 5% CO 2 . Cells were then transfected with 1 µ g each of the reporter (pGL2, pGL3 or p β gal-Basic) and effector plasmid (plasmid coding for Cbfa1, ER α , cfos or the control vector pCMV5) using FuGENE ™ 6 transfection reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA). The constructs (1 µ g each in a total volume of 20 µ L in TE buffer, pH 8.0) were mixed with diluted FuGENE 6 reagent (194 µ L serum-free medium + 6 µ L FuGENE) and incubated for 15 min at room temperature. The DNA-FuGENE mixture was then added dropwise to the plates, and the cells were incubated for an additional 36 h. Following transfection, the plates were washed twice with PBS (Life Technologies) and then lysed with 100 µ L of lysis buffer that was provided with the luciferase or β -galactosidase ( β -gal) reporter gene assay kit (Roche Molecular Biochemicals). The cell extracts were spun down for 2 min at 14 000 rpm in a microcentrifuge (Eppendorf ® 5415C, Brinkmann Instruments, Westbury, NY, USA) to precipitate cellular debris. Twenty microliters of the supernatant was transferred to white opaque microtiter plates and the luciferase or β -gal activity was measured as per the manufacturer's instructions using an automated injection MLX ™Luminometer (Dynex, Chantilly, VA, USA). The luciferase and β -gal activity values represent the integral value of light emitted over a period of two seconds and are expressed as fold induction over basal (control vector transfected) levels.
Sequence Analysis
The sequences of pGL2, pGL3 and p β gal-Basic vectors were analyzed for the presence of OSE 2 (Cbfa1-binding site: 5 ′ -AACCACA-3 ′ ) and OSE 2 -like elements, AP-1 site (5 ′ -TGAG/CTCA-3 ′ ), and estrogen response elements (ERE: GGTCAnnnTGACC) using the GCG Wisconsin package (Genetics Computer Group, Madison, WI, USA).
RESULTS
Cbfa1 is an osteoblast-specific transcription factor that is essential for osteoblast differentiation and bone formation (6, 10, 16, 18) . It is expressed abundantly in osteoblasts and activates transcription of several genes expressed in osteoblasts by interacting with DNA sequence elements called OSE 2 s that are found in the control regions of these genes (5, 6) .
The luciferase reporter systems, pGL2 and pGL3, have recently been used for the analysis of bone-specific promoters and their regulation by the osteoblast-specific transcription factor Cbfa1 (3, 9, 20) . For the present study we first evaluated whether or not Cbfa1 regulates the pGL3 vector using randomly occurring osteoblast-specific, cis-acting elements (OSE 2 ) (5,15) in the vector sequence. This was studied by transient co-transfection assays with pGL3 as a reporter plasmid and either pCMV5-Cbfa1 (as the effector plasmid) or the empty vector pCMV5 (as the control plasmid) in COS-1 cells that do not express any of the Cbfa proteins (11) .
Measuring the luciferase activity in cell extracts revealed that the pGL3 vector was activated by Cbfa1, which resulted in a 6.8-fold increase in luciferase activity compared to that in control vector transfected cells (Table 1 ). The induction of luciferase activity varied from 3.3-to 6.8-fold in our experiments. Cbfa1 also led to an approximate twofold increase in luciferase activity when pGL2 was used as a reporter plasmid (data not shown). However, Cbfa1 did not result in transactivation of a β -gal reporter plasmid (p β gal-Basic), under the same conditions (Table 1) . Because Cbfa1 is an osteoblast-specific transcription factor, we tested whether pGL3 is transactivated by Cbfa1 in an osteoblastic cell line that expresses endogenous Cbfa1. Co-transfection of Cbfa1 in the osteoblast-like osteosarcoma cell line SaOS2 also resulted in a 3.5-fold increase in luciferase activity compared to empty vector transfected cells (Table 1) . This is reminiscent of Cbfa1 activating transcription using cryptic promoter and enhancer elements in the pGL2 and pGL3 vector sequences. We analyzed the DNA sequences of pGL2 and pGL3 vectors for the presence of OSE 2 and OSE 2 -like elements using the GCG software. Our analysis revealed the presence of three consensus OSE 2 sites at positions 1806 and 1987 (downstream of the luciferase coding sequence), at position 4106 (approximately 800 bp upstream of the luciferase coding sequence), and several OSE 2 -like sites to which Cbfa1 has been shown to bind with lower affinity (6, 19 (19) . We further tested to see if other transcription factors such as ER αand c-fos could also regulate luciferase expression from the promoterless vectors. Cotransfection of SaOS2 cells with ER α and either pGL2 or pGL3 led to a 4.4-and 4.1-fold increase in luciferase activity from pGL2 and pGL3, respectively (Figure 1) . Conversely, co-transfection of the c-fos expression construct did not lead to enhanced levels of luciferase expression from pGL2 and pGL3 (Figure 1 ).
DISCUSSION
Our results show that co-transfection of Cbfa1 along with pGL3 reporter plasmid results in transactivation and enhanced luciferase expression. Vectors containing the luciferase reporter gene are often used in analysis of the regulatory regions of many genes. Previous studies have suggested that cryptic promoter elements in the vector sequences flanking the luciferase reporter gene could lead to spurious luciferase expression (4, 8, 13, 17, 19) . To obviate this limitation, recent versions of the luciferase reporter vectors such as pGL3, a promoterless and enhancerless luciferase vector, have been engineered to minimize this effect (19) . However, in the present study, we demonstrate that the promoterless pGL3 (as well as pGL2) vectors can be transactivated by an osteoblast-specific transcription factor, Cbfa1. The transactivation effect on these luciferase vectors was evident in osteoblastic and non-osteoblastic cell lines. This effect was not observed in a control vector containing the β -gal reporter gene, which suggests that the effect is mediated by DNA elements in pGL2 and pGL3. Overexpression of ER αalso resulted in transactivation of pGL2 and pGL3 luciferase vectors. The fact that ER αresulted in transactivation even in the absence of any added ligand suggests that estrogenic compounds (lipophilic impurities in phenol red) present in the culture media could serve as the ligand (1, 2) or that ER α could be activated in a ligand-independent fashion (7, 21) .
These results suggest that cryptic enhancer elements in the luciferase vectors may mediate the action of Cbfa1 or ER α . At present, the mechanism for the observed effect of Cbfa1 or ER αon these luciferase reporters remains unclear. Our analysis revealed putative canonical Cbfa1 binding sites (OSE 2 ) and imperfect EREs (half-sites) upstream and downstream of the luciferase gene that could mediate these effects. However, it is important to note that the mere presence of these sites may not be sufficient to explain the observed transactivation. The context in which the elements occur is probably more important for them to be functional. For example, there are more OSE 2 elements present in the pGL2 vector sequence compared to that of pGL3, but the context in which they occur may make them less attractive for Cbfa1 to bind. As such, they could explain the lower transactivation of luciferase expression observed with pGL2. Similarly, p β gal-Basic, which contains nine canonical OSE 2 elements, is not transactivated by Cbfa1. Furthermore, the contribution of spurious expression from the vectors needs to be examined in the context of a real promoter in position. Insertion of promoter sequences into the multiple cloning sites will alter the spatial and possibly the functional relationship of OSE 2 and ERE with respect to the luciferase reporter gene. Therefore, it remains to be empirically determined whether OSE 2 and ERE are functional in the context in which they appear with or without a promoter.
It is also possible that the effects observed with Cbfa1 and ER αoccur indirectly by the activation of another factor that in turn activates cryptic promoter and enhancer elements in the pGL2 and pGL3 vector sequences. It is likely that other transcription factors could also interact with a cognate element that may occur at random in the luciferase vector sequences. Indeed, the thyroid hormone receptors (TR αand β ) have been shown to alter luciferase expression from two different TK-LUC vectors in the absence and presence of ligand, which suggests the presence of a thyroid hormone response element in the luciferase coding sequence (14) . Also, a very high level of transactivation of promoterless luciferase reporter vectors pXP1 and pXP2 by C/EBP αhas been reported (13) . However, c-fos overexpression did not result in transactivation of pGL2 and pGL3, even though sequence analy - sis revealed the presence of one consensus and three non-consensus AP-1 sites (8, 12) in pGL2 and one non-consensus AP-1 site in pGL3. Although AP-1 sites that are present in pXP2 luciferase vector (8) and in pUC plasmids (12) have been shown to confound promoter analysis, the absence of transactivation of pGL2 and pGL3 by the c-fos expression plasmid suggests that the AP-1 sites present in these two vectors are probably nonfunctional in the context in which they appear.
Our results indicate the need to exercise caution in the functional analyses of gene regulatory sequences using pGL2 and pGL3 luciferase reporter vectors. The data presented in this paper also reinforce (i)the need to test the background expression levels with a particular transcription factor and promoterless luciferase reporter vector combination and (ii) the need to perform appropriate controls to ensure meaningful interpretation of results in promoter transactivation/repression studies.
INTRODUCTION
Lipopolysaccharide (LPS, endotoxin) consists of an O-specific polysaccharide chain, a core oligosaccharide and a fatty acid-bearing component termed Lipid A, which displays most of the endotoxic properties of the complete molecule (12) . LPS alters mammalian cell function by binding to cell surface receptors such as the CD14 molecule. Following LPS binding, extensive signal transduction occurs, including activation of the extracellular signal-regulated kinase (ERKs) superfamily of enzymes (4) . Phosphorylated ERKs translocate to the nucleus and activate transcription factors such as the ternary complex factor, Elk-1. Elk-1 is important in the pathway leading to transcription of many immediate early (IE) genes, including c-fos (14) . However, LPS can directly activate two important intracellular enzymes, ERK-2 and protein kinase C (PKC), even in a cell-free system devoid of known endotoxin receptors (3). Furthermore, LPS accumulates inside cells during the replication of invasive bacteria (7) and can enter some cells types by transmembrane diffusion (10) .
These studies suggest that LPS may also influence cell function when present in the intracellular compartment of mammalian tissues. To test this hypothesis, techniques permitting the reliable translocation of endotoxin into a wellcharacterized mammalian cell line are desirable. Here, we describe the successful use of polycationic lipids, widely used for DNA transfection, for the translocation of E. coli LPS into the cytoplasm of HeLa cells. Because LPS activates ERK-2 and PKC in vitro, and both of these enzymes are known regulators of c-fos expression, the ability of translocated LPS molecules to enhance levels of c-Fos in HeLa cells was also examined.
MATERIALS AND METHODS
HeLa cells were cultured in a 37°C, 5% CO 2 environment using DMEM 
